Topics in hospital pharmacy management
An adverse drug reaction reporting system as an integral part of a drug-usage evaluation program
Abstract
The Adverse Drug Reaction program at CSMC identifies patients whose charts have been encoded with an ICD-9 code of E930 through E949, inclusively. Incidences per drug or drug category have permitted the Department of Pharmacy, acting through the Pharmacy and Therapeutics Committee, to review patient charts, identify trends and risk factors, and subsequently develop usage criteria for DUE studies. It is hoped that these activities will result in an improvement in usage of these drugs and a reduction in adverse drug reactions to them.
Source and rights
Published by Topics in hospital pharmacy management, 1991. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Published
- 1991
- Applies to
- 🇪🇺 Europe
- Scope
- Regional
- Journal
- Topics in hospital pharmacy management
- PubMed
- 10128635
- Added to Prognia
- 16 July 2026



